Haiqing Wang

Visionary
DISC Type : Ds

Senior Director, Research at Alnylam Pharmaceuticals

New York City Metropolitan Area, United States

Overview

Haiqing Wang is a Senior Director at Alnylam Pharmaceuticals specializing in Drug Metabolism and Pharmacokinetics (DMPK). With a Ph. D. from the University of Minnesota, her career features extensive experience in oncology and quantitative translation at Takeda. Colleagues have described her as a well-rounded and knowledgeable scientist.

She is a frequent speaker at industry symposiums, recently presenting on the evolution of First-in-Human (FIH) dose selection for biologics in oncology.

Personality Overview

Risk Tolerant

Early Adopter

Fast But Thoughtful

They exhibit a rare combination of being result-oriented but patient at the same time.  Reading between the lines and seeing beyond your words comes naturally to them. They might take some time to make their mind up but once they do, they don't change it easily.

Topics They Care About

Drug Metabolism (DMPK)
Her career at Alnylam and Takeda is focused on DMPK, with specific expertise in biologics, oncology, and quantitative modeling for drug development.
Oncology Therapeutics
She has deep experience in oncology, speaking on topics like CAR-T cell therapies and First-in-Human dose selection for cancer treatments.
Translational Modeling
Her research interest is in model-based PK/PD analysis and using quantitative systems pharmacology (QSP) to bridge preclinical and clinical development.

Media Appearances

Haiqing has no verified media appearances

Work History

1-2025
Senior Director, Research at Alnylam Pharmaceuticals
2-2023 - 2-2025
Senior Director, DMPK at Alnylam Pharmaceuticals
11-2021 - 2-2023
Director, Head of Oncology DMPK and Quantitative Translation at Takeda Oncology
7-2020 - 11-2021
Scientific Director, Oncology DMPK at Takeda Oncology
5-2018 - 7-2020
Associate Director, DMPK at Takeda Oncology

Education

1999 - 2004
Ph.D. from University of Minnesota

More Information

Social Presence :

Prographics :

Exp : 18 Location : New York City Metropolitan Area, United States Job Level : Senior Designation : Senior Director, Research at Alnylam Pharmaceuticals
URL has been copied!

Insights For Selling To Haiqing

During A Call Or A Meeting

DO's

  • During followups, use phone or text if needed, they should be fine
  • Ask them at the end if they see a strong value prop in your product; expect an honest answer
  • Stick to your standard pitch and qualifying script, don't try to wing it

DONT's

  • Avoid putting conscious effort into relationship-building
  • Don't focus too much on mutual contacts or bother about other stakeholders, focus on them
  • Don't take their patience for granted, avoid long-winding sermons

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Haiqing is

  • Strong proof of impact and their conviction will matter the most, but they wouldn't want to act unilaterally either
  • Will you ever get a clear answer from Haiqing

  • They will say no if they are not convinced but you will have to prompt them.

Insights For Deal Planning

    How fast (or slow) will Haiqing move?

  • They will want to understand things well but can move fast once they have a clear picture.
  • Can Haiqing take some risk or not?

  • They have good risk tolerance but are likely to think it through once or twice.

You And Haiqing

Personality Compatibility


Other Alnylam Pharmaceuticals Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.